We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
-11.14%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$309M
AUM Growth
-$35.7M
Cap. Flow
+$5.78M
Cap. Flow %
1.87%
Top 10 Hldgs %
27.1%
Holding
113
New
2
Increased
38
Reduced
26
Closed
7

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$261K
2
BA icon
Boeing
BA
+$248K
3
TROW icon
T. Rowe Price
TROW
+$214K
4
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$210K
5
GE icon
GE Aerospace
GE
+$209K

Sector Composition

Rank Sector Weight
1 Healthcare 15.27%
2 Technology 13.05%
3 Industrials 11.58%
4 Consumer Staples 11.18%
5 Consumer Discretionary 8.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.99T
$12.9M 4.17%
50,095
+49
+0.1% +$13.3K
IVV icon
2
iShares Core S&P 500 ETF
IVV
$879B
$12.1M 3.91%
31,833
+1,284
+4% +$528K
ABBV icon
3
AbbVie
ABBV
$448B
$8.44M 2.73%
55,094
-1,252
-2% -$191K
AAPL icon
4
Apple
AAPL
$4.8T
$7.9M 2.56%
57,764
+455
+0.8% +$68.9K
GIS icon
5
General Mills
GIS
$20.1B
$7.71M 2.5%
102,126
-175
-0.2% -$12.3K
TSCO icon
6
Tractor Supply
TSCO
$15.9B
$7.58M 2.45%
195,455
-485
-0.2% -$19.7K
FAST icon
7
Fastenal
FAST
$51.4B
$7.22M 2.34%
289,348
-10
-0% -$269
MA icon
8
Mastercard
MA
$484B
$6.83M 2.21%
21,660
+197
+0.9% +$67.8K
IJR icon
9
iShares Core S&P Small-Cap ETF
IJR
$109B
$6.67M 2.16%
72,203
+1,121
+2% +$111K
ABT icon
10
Abbott
ABT
$177B
$6.38M 2.07%
58,729
+675
+1% +$76.7K
MCD icon
11
McDonald's
MCD
$190B
$6M 1.94%
24,285
-60
-0.2% -$14.8K
UPS icon
12
United Parcel Service
UPS
$96.2B
$5.96M 1.93%
32,658
+230
+0.7% +$42K
CSCO icon
13
Cisco
CSCO
$436B
$5.81M 1.88%
136,191
-345
-0.3% -$16.5K
CVS icon
14
CVS Health
CVS
$137B
$5.69M 1.84%
61,427
-1,200
-2% -$117K
MRK icon
15
Merck
MRK
$307B
$5.69M 1.84%
62,394
-170
-0.3% -$15.1K
GOOGL icon
16
Alphabet (Google) Class A
GOOGL
$4.3T
$5.63M 1.82%
51,640
+1,040
+2% +$122K
WMT icon
17
Walmart Inc
WMT
$893B
$5.61M 1.82%
138,498
-2,157
-2% -$99.5K
BRK.B icon
18
Berkshire Hathaway Class B
BRK.B
$1.06T
$5.34M 1.73%
19,557
-41
-0.2% -$12.9K
PG icon
19
Procter & Gamble
PG
$347B
$5.26M 1.7%
36,565
+420
+1% +$63.1K
LH icon
20
Labcorp
LH
$23.1B
$5.12M 1.66%
25,443
+678
+3% +$145K
CL icon
21
Colgate-Palmolive
CL
$73.6B
$5.04M 1.63%
62,851
+295
+0.5% +$23.1K
CHRW icon
22
C.H. Robinson
CHRW
$24.3B
$4.94M 1.6%
48,774
-260
-0.5% -$27.1K
XYL icon
23
Xylem
XYL
$28.7B
$4.91M 1.59%
62,835
+1,145
+2% +$94.5K
IEMG icon
24
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
$4.91M 1.59%
100,025
+3,973
+4% +$205K
LIN icon
25
Linde
LIN
$237B
$4.89M 1.58%
17,003
-31
-0.2% -$9.68K

Similar funds

Boston Research & Management's Q2 2022 Portfolio in Review

As of Q2 2022, Boston Research & Management held 113 positions worth $309M, down 10% from $344M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Boston Research & Management's Q2 2022 filing shows 2 new, 38 increased, 26 reduced and 7 closed positions. Its largest new stake was Qorvo: 29,510 shares worth $2.78M. The largest sale was Tesla, an estimated $261K.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

  • Boston Research & Management's largest Q2 2022 buy was Qorvo: 29,510 shares worth $2.78M.
  • Boston Research & Management added most to iShares Core S&P 500 ETF in Q2 2022, an estimated $528K increase.
  • Boston Research & Management's biggest Q2 2022 reduction was AbbVie, cutting an estimated $191K.
  • Boston Research & Management fully exited Tesla in Q2 2022, selling an estimated $261K.
  • Boston Research & Management's ten largest holdings make up 27% of its $309M portfolio in Q2 2022.
  • Boston Research & Management opened 2 new positions and closed 7 in Q2 2022.
  • Boston Research & Management's portfolio value fell 10% quarter-over-quarter to $309M.

Based on Boston Research & Management's 13F filing for Q2 2022, filed 11 Aug 2022.